Clinical Trial Update: COMPARISON OF EFFICACY AND SAFETY OF NARROWBAND UVB WITH 0.1% TACROLIMUS VS NARROWBAND UVB WITH 0.005% CALCIPOTRIOL IN TREATMENT OF VITILIGO [EARLY_Phase 1]

View source ↗

Summary

An early Phase 1 trial compares narrowband UVB therapy combined with topical tacrolimus 0.1% versus narrowband UVB therapy combined with calcipotriol 0.005% for…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Vitiligo

Drugs mentioned

• Calcipotriol (calcipotriol)
• Tacrolimus (topical) (tacrolimus)

Snippet

Sponsor: Dr ayesha wahid | Conditions: Vitiligo - Macular Depigmentation, Tacrolimus | EARLY_Phase 1 | Status: ENROLLING_BY_INVITATION